151 related articles for article (PubMed ID: 25432328)
1. The evaluation of Nesfatin-1 levels in patients with OSAS associated with metabolic syndrome.
Aksu O; Aydın B; Doguç DK; Ilhan I; Ozturk O; Altuntas A; Demirkan H; Koroglu BK; Tamer MN
J Endocrinol Invest; 2015 Apr; 38(4):463-9. PubMed ID: 25432328
[TBL] [Abstract][Full Text] [Related]
2. Is There a Relationship between Obstructive Sleep Apnea Syndrome Severity and Nesfatin-1?
Araz O; Yilmazel Ucar E; Dorman E; Bayraktutan Z; Yayla M; Yilmaz N; Acemoglu H; Halici Z; Akgun M
Respiration; 2015; 90(2):105-10. PubMed ID: 26088934
[TBL] [Abstract][Full Text] [Related]
3. Decreased levels of serum nesfatin-1 in patients with obstructive sleep apnea syndrome.
Shen P; Han Y; Cai B; Wang Y
Sleep Breath; 2015 May; 19(2):515-22. PubMed ID: 25056666
[TBL] [Abstract][Full Text] [Related]
4. Visceral obesity is associated with the metabolic syndrome and elevated plasma retinol binding protein-4 level in obstructive sleep apnea syndrome.
Makino S; Fujiwara M; Suzukawa K; Handa H; Fujie T; Ohtaka Y; Komatsu Y; Aoki Y; Maruyama H; Terada Y; Hashimoto K; Sugimoto T
Horm Metab Res; 2009 Mar; 41(3):221-6. PubMed ID: 19003725
[TBL] [Abstract][Full Text] [Related]
5. NUCB2 gene polymorphism and its relationship with nesfatin-1 levels in polycystic ovary syndrome.
Taskin MI; Eser B; Adali E; Kara H; Cuce C; Hismiogulları AA
Gynecol Endocrinol; 2016; 32(1):46-50. PubMed ID: 26369257
[TBL] [Abstract][Full Text] [Related]
6. [Metabolic profile in obese patients with obstructive sleep apnea. A comparison between patients with insulin resistance and with insulin sensitivity].
Dumitrache-Rujinski S; Dinu I; Călcăianu G; Erhan I; Cocieru A; Zaharia D; Toma CL; Bogdan MA
Pneumologia; 2014; 63(2):100-2, 104-6. PubMed ID: 25241557
[TBL] [Abstract][Full Text] [Related]
7. Fasting and postprandial levels of a novel anorexigenic peptide nesfatin in childhood obesity.
Anık A; Çatlı G; Abacı A; Küme T; Bober E
J Pediatr Endocrinol Metab; 2014 Jul; 27(7-8):623-8. PubMed ID: 24825087
[TBL] [Abstract][Full Text] [Related]
8. The relation of serum nesfatin-1 level with metabolic and clinical parameters in obese and healthy children.
Abaci A; Catli G; Anik A; Kume T; Bober E
Pediatr Diabetes; 2013 May; 14(3):189-95. PubMed ID: 23346951
[TBL] [Abstract][Full Text] [Related]
9. The association of serum nesfatin-1 and ghrelin levels with metabolic syndrome in patients with schizophrenia.
Ünal K; Yüksel RN; Turhan T; Sezer S; Yaylaci ET
Psychiatry Res; 2018 Mar; 261():45-49. PubMed ID: 29278806
[TBL] [Abstract][Full Text] [Related]
10. Effects of plasma ghrelin, obestatin, and ghrelin/obestatin ratio on blood pressure circadian rhythms in patients with obstructive sleep apnea syndrome.
Liu W; Yue H; Zhang J; Pu J; Yu Q
Chin Med J (Engl); 2014; 127(5):850-5. PubMed ID: 24571875
[TBL] [Abstract][Full Text] [Related]
11. Metabolic syndrome in Japanese patients with obstructive sleep apnea syndrome.
Sasanabe R; Banno K; Otake K; Hasegawa R; Usui K; Morita M; Shiomi T
Hypertens Res; 2006 May; 29(5):315-22. PubMed ID: 16832151
[TBL] [Abstract][Full Text] [Related]
12. NUCB2/nesfatin-1 is associated with elevated scores of anxiety in female obese patients.
Hofmann T; Stengel A; Ahnis A; Buße P; Elbelt U; Klapp BF
Psychoneuroendocrinology; 2013 Nov; 38(11):2502-10. PubMed ID: 23796625
[TBL] [Abstract][Full Text] [Related]
13. Obstructive sleep apnoea syndrome and the metabolic syndrome in an internal medicine setting.
Angelico F; del Ben M; Augelletti T; de Vita R; Roma R; Violi F; Fabiani M
Eur J Intern Med; 2010 Jun; 21(3):191-5. PubMed ID: 20493421
[TBL] [Abstract][Full Text] [Related]
14. Visceral Obesity Mediates the Association Between Metabolic Syndrome and Obstructive Sleep Apnea Syndrome.
Bozkurt NC; Beysel S; Karbek B; Unsal İO; Cakir E; Delibasi T
Metab Syndr Relat Disord; 2016 May; 14(4):217-21. PubMed ID: 27003688
[TBL] [Abstract][Full Text] [Related]
15. Alterations of circulating NUCB2/nesfatin-1 during short term therapeutic improvement of anxiety in obese inpatients.
Hofmann T; Weibert E; Ahnis A; Obbarius A; Elbelt U; Rose M; Klapp BF; Stengel A
Psychoneuroendocrinology; 2017 May; 79():107-115. PubMed ID: 28273586
[TBL] [Abstract][Full Text] [Related]
16. Plasma nesfatin-1 level in obese patients after acupuncture: a randomised controlled trial.
Guo Y; Xing M; Sun W; Yuan X; Dai H; Ding H
Acupunct Med; 2014 Aug; 32(4):313-7. PubMed ID: 24813558
[TBL] [Abstract][Full Text] [Related]
17. Obstructive sleep apnoea syndrome, plasma adiponectin levels, and insulin resistance.
Makino S; Handa H; Suzukawa K; Fujiwara M; Nakamura M; Muraoka S; Takasago I; Tanaka Y; Hashimoto K; Sugimoto T
Clin Endocrinol (Oxf); 2006 Jan; 64(1):12-9. PubMed ID: 16402923
[TBL] [Abstract][Full Text] [Related]
18. [Association between serum lipoprotein lipase level and dyslipidemia in patients with obstructive sleep apnea syndrome].
Li J; Zhang Y; Wang J; Feng P; Chen R; Cao Y; Liu C
Zhonghua Yi Xue Za Zhi; 2014 Feb; 94(6):403-7. PubMed ID: 24754980
[TBL] [Abstract][Full Text] [Related]
19. Obstructive sleep apnea syndrome is associated with metabolic syndrome rather than insulin resistance.
Onat A; Hergenç G; Uyarel H; Yazici M; Tuncer M; Doğan Y; Can G; Rasche K
Sleep Breath; 2007 Mar; 11(1):23-30. PubMed ID: 17061139
[TBL] [Abstract][Full Text] [Related]
20. Leptin and ghrelin levels in patients with obstructive sleep apnea syndrome.
Ulukavak Ciftci T; Kokturk O; Bukan N; Bilgihan A
Respiration; 2005; 72(4):395-401. PubMed ID: 16088283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
